Showing results (221-230 of 5,042) with videos related to

Sort By:
Pageof 505
Multiple Sclerosis and Related Disorders|March 12, 2017
Sex differences in outcomes of disease-modifying treatments for multiple sclerosis: A systematic reviewRui Li, Xiaobo Sun, Yaqing Shu, et al.
Multiple Sclerosis and Related Disorders|March 12, 2017
Comparing epidemiology and baseline characteristic of multiple sclerosis and neuromyelitis optica: A case-control studySharareh Eskandarieh, Saharnaz Nedjat, Ibrahim Abdollahpour, et al.
Multiple Sclerosis and Related Disorders|March 12, 2017
Is multiple sclerosis a length-dependent central axonopathy? The case for therapeutic lag and the asynchronous progressive MS hypothesesGavin Giovannoni, Gary Cutter, Maria Pia Sormani, et al.
Multiple Sclerosis and Related Disorders|March 12, 2017
Discontinuation of disease modifying treatments in middle aged multiple sclerosis patients. First line drugs vs natalizumabJan Fagius, Amalia Feresiadou, Elna-Marie Larsson, et al.
Multiple Sclerosis and Related Disorders|March 12, 2017
The varieties of psychosis in multiple sclerosis: A systematic review of casesCarlos R Camara-Lemarroy, Beatriz E Ibarra-Yruegas, Rene Rodriguez-Gutierrez, et al.
Multiple Sclerosis and Related Disorders|August 27, 2022
Delayed cognitive processing and treatment status quo bias in early-stage multiple sclerosisGustavo Saposnik, Sanketh Andhavarapu, Susana Sainz de la Maza, et al.
Multiple Sclerosis and Related Disorders|August 28, 2022
The CELLO trial: Protocol of a planned phase 4 study to assess the efficacy of Ocrelizumab in patients with radiologically isolated syndromeErin E Longbrake, Le H Hua, Ellen M Mowry, et al.
Multiple Sclerosis and Related Disorders|August 28, 2022
Effects of hippotherapy simulation exercise vs. conventional home exercises on muscle strength and balance in people with multiple sclerosis: A randomized controlled trialEnder Salbaş, Ali Yavuz Karahan
Multiple Sclerosis and Related Disorders|October 18, 2022
Biomarkers of demyelination and axonal damage are decreased after autologous hematopoietic stem cell transplantation for multiple sclerosisChristina Zjukovskaja, Anders Larsson, Honar Cherif, et al.
Multiple Sclerosis and Related Disorders|October 18, 2022
Peripheral neuropathy and MOG-IgG: A clinical and neuropathological retrospective studyAlessandro Dinoto, Noemi Maria Licciardi, Markus Reindl, et al.
Pageof 505